Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MKK700
- Development stage
- Preclinical
- Lead developer
- MAXVAX Biotechnology
- Modality
- Small Molecules
- Administration
- Intramuscular, Subcutaneous
01
Overview
MKK700 is a small molecule toll-like receptor 7 and 8 (TLR7/8) agonist developed by MAXVAX Biotechnology as part of its proprietary adjuvant platform. It is designed to enhance the efficacy of vaccines by stimulating the innate immune system, specifically through the activation of TLR7 and TLR8 pathways in endosomes. This activation leads to the secretion of pro-inflammatory cytokines (such as IFN-alpha, IL-12, and TNF-alpha) and promotes the maturation and migration of antigen-presenting cells, thereby strengthening the subsequent adaptive immune response. MKK700 is being evaluated in preclinical studies for its potential to serve as a potent adjuvant in various vaccine formulations, including those for infectious diseases and oncology.
- Other names
- TLR7/8 agonist adjuvant
02
Targets
TLR8 (Toll-like receptor 8)TLR7 (Toll-like receptor 7)
Beyond the preview
Go deeper on MKK700.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MKK700.